Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chinook Therapeutics (KDNY)
NASDAQ:KDNY
Holding KDNY?
Track your performance easily
See the Price Targets and Ratings of:
KDNY Analyst Ratings
Hold
2 Buy
10 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KDNY Stock 12 Month Forecast
Average Price Target
$40.36
▼(-0.07% Downside)
| Highest Price Target$47.00 | Average Price Target$40.36 | Lowest Price Target$33.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wedbush
Downgraded
08/08/23
Wells Fargo
Downgraded
08/01/23
H.C. Wainwright
Reiterated
06/21/23
Stifel Nicolaus
Downgraded
06/13/23
SVB Securities
Downgraded
06/13/23
Cantor Fitzgerald
Downgraded
06/12/23
Guggenheim
Downgraded
06/12/23
Piper Sandler
Assigned
06/12/23
Bloom Burton
Downgraded
06/12/23
William Blair
Downgraded
06/12/23
Oppenheimer
$34
Buy
-15.82%
Downside
Reiterated
02/28/23
Oppenheimer Maintains Outperform on Chinook Therapeutics, Raises Price Target to $34
―
Evercore ISI
―
Hold
―
Downgraded
06/14/23
Chinook Therapeutics downgraded to In Line from Outperform at Evercore ISIChinook Therapeutics downgraded to In Line from Outperform at Evercore ISI
Best Analysts Covering Chinook Therapeutics
Which Analyst Should I Follow If I Want to Buy KDNY and Sell After:
1 Month
xxx
Success Rate
4/8 ratings generated profit
Average Return
+0.26%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +0.26% per trade.
3 Months
xxx
Success Rate
3/8 ratings generated profit
Average Return
+0.44%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of +0.44% per trade.
1 Year
Success Rate
4/8 ratings generated profit
Average Return
+11.58%
reiterated a buy rating 2 years ago
Copying Justin Kim's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.58% per trade.
2 Years
xxx
Success Rate
8/8 ratings generated profit
Average Return
+61.75%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +61.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KDNY Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
KDNY Financial Forecast
KDNY Stock Forecast FAQ
What is KDNY’s average 12-month price target, according to analysts?
Based on analyst ratings, Chinook Therapeutics’s 12-month average price target is $40.36.
What is KDNY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KDNY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KDNY a Buy, Sell or Hold?
Chinook Therapeutics has a consensus rating of Hold which is based on 2 buy ratings, 10 hold ratings and 0 sell ratings.
What is Chinook Therapeutics’s price target?
The average price target for Chinook Therapeutics is $40.36. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $47.00 ,the lowest forecast is $33.00. The average price target represents -0.07% Decrease from the current price of $40.39.
The highest analyst price target is $47.00 ,the lowest forecast is $33.00. The average price target represents -0.07% Decrease from the current price of $40.39.
What do analysts say about Chinook Therapeutics?
Chinook Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of KDNY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.